Devon Funds head of retail Greg Smith said the mood of the market was in a "vacuum" and investors were holding back to see what companies said in their annual meetings.
Green Cross Health's annual meeting kicked off the week yesterday. Director John Bolland had to shake off a challenge to his re-election but shareholders were pleased overall with the company's results. The company's shares were up 1.4 per cent to $1.42 today.
AGMs ahead
Rest home operator Ryman Healthcare, fleet company Eroad, logistics group Mainfreight and cancer diagnostics company Pacific Edge are also preparing for their annual meetings this week. Ryman Healthcare shares were up 0.9 per cent to $8.98 and Mainfreight rose 0.6 per cent to $71.15. Eroad had the biggest day's gain yesterday but today its shares were flat at $2.10 per share.
Smith said Ryman Healthcare and Mainfreight would be preparing to answer shareholders' questions around Covid-19 and future issues on the horizon, while Eroad was likely to be quizzed about the issues with its internal management.
In international waters, big tech companies like Microsoft and Google's Alphabet Group have their earnings out tomorrow, with Apple releasing its results on Thursday. Smith said Snapchat's disappointing earnings last week didn't rock the technology stock boat in NZ's market, but how Microsoft, Google and Apple's earnings turned out would have a "much bigger" effect.
Scott Technology was up 1.5 per cent to $2.80, Pacific Edge was down 1.2 per cent to 81 cents and Blis Technologies was up 3 per cent to 34 cents. NZ Automotive Investments had a large rise, up 13 per cent to 52 cents, while software company Enprise Group had a large fall, down 10.2 per cent to $1.15.
Fonterra announced this morning that it had appointed Emma Parsons as its managing director, strategy and optimisation. Parsons will start her new role on August 1 as part of Fonterra's planned new capital structure. Fonterra Shareholders' Fund was down 0.7 per cent to $3.08 by early evening.
Medicinal cannabis company Rua Bioscience was up 3.3 per cent to 31.5 cents after saying it had reached a five-year deal with Motagon, a European medicinal cannabis distributor, to become its preferred Australasian supplier of medicinal cannabis products. Waikato-based medicinal cannabis firm Cannasouth was also up 2.5 per cent to 41 cents.
The NZ dollar was trading at 62.72 US cents at 3pm in Wellington, up from 62.31 cents on Monday. The trade-weighted index was at 71.26, from 71 yesterday.
- BusinessDesk